Cancer patients can respond very differently to the same treatment, while current testing may not reliably identify the therapy most likely to work for each tumor.
R&D Focus
Genomics and multi-omics for patient stratification and treatment selection
Innovative Solution
Acornmed provides tumor genetic testing and detection solutions intended to provide clinical solutions with genomics as the core of tumor precision medicine. It also provides advanced molecular diagnosis for solid and blood tumor genetic testing, enabling cancer patients to receive comprehensive and personalized early detection test results.
Acornmed provides tumor genetic testing and detection solutions intended to provide clinical solutions with genomics as the core of tumor precision medicine. It also provides advanced molecular diagnosis for solid and blood tumor genetic testing, enabling cancer patients to receive comprehensive and personalized early detection test results.
Something missing or incorrect on this page? Help us enrich this information
